SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer

Clinical trial NCT02766140 · TERMINATED

Trial details

NCT number: NCT02766140
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Non Squamous Non Small Cell Lung

Start date: 2016-06-01
Primary completion: 2016-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.